[This corrects the article DOI: 10.3389/fbioe.2019.00452.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080608 | PMC |
| http://dx.doi.org/10.3389/fbioe.2021.674507 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade" [Journal of Controlled Release 332 (2021) 194-209].
J Control Release
January 2025
Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China. Electronic address:
Corrigendum to "Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies" [Int. J. Biol. Macromol. 282 (2024) 136600].
Int J Biol Macromol
January 2025
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Electronic address:
Corrigendum to "Gold nanoparticles synergize with bacterial lipopolysaccharide to enhance class A scavenger receptor dependent particle uptake in neutrophils and augment neutrophil extracellular traps formation" [Ecotoxicol. Environ. Saf. 211 (2021) 111900].
Ecotoxicol Environ Saf
October 2024
Medical Research Center, Southwest Hospital, Army Military Medical University, Chongqing 400038, China. Electronic address:
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Front Immunol
July 2024
Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrigendum to "Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells" [Neoplasia 39 (2023), 100893].
Neoplasia
September 2024
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!